Camrelizumab Combined With Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To evaluate the clinical efficacy and safety of camrelizumab combined with apatinib mesylate, nab-paclitaxel and S-1
Epistemonikos ID: c7af35cbe637656ee8a87d8e5a1622d80c1a179f
First added on: May 06, 2024